机译:结核病新药研发的挑战
Department of Antimicrobial Research, Janssen Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium;
Department of Antimicrobial Research, Janssen Research and Development, Johnson & Johnson, Val de Reuil 27106, Cedex, France;
Department of Antimicrobial Research, Janssen Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium;
Department of Antimicrobial Research, Janssen Research and Development, Johnson & Johnson, Val de Reuil 27106, Cedex, France;
Department of Antimicrobial Research, Janssen Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium;
机译:早期结核病药物发现过程中发现新化学实体涉及的策略和挑战
机译:结核病药物发现中的当前挑战
机译:结核病药物发现的挑战和机遇:行业观点
机译:用于药物发现的HRMS Snapshot PK定量和结核病抗生素的代谢物筛选
机译:结核分枝杆菌的耐药性:转运蛋白P-糖蛋白的调查和喀麦隆肺结核患者耐药性结核病改善诊断的评估
机译:使用化学系统生物学进行药物发现:重新定位安全的通用丹坦治疗多种药物和广泛耐药的结核病
机译:早期结核病药物发现中新化学实体发现的策略和挑战